Allison Transmission Holdings Inc
For the period ended Dec 31, 2024. Filed Feb 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 13, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
NOTE 1. OVERVIEW
Allison Transmission Holdings, Inc. and its subsidiaries (“Allison” or the “Company”) is a leading designer and manufacturer of propulsion solutions for commercial and defense vehicles and the largest global manufacturer of medium- and heavy-duty fully automatic transmissions. The business was founded in 1915 and has been headquartered in Indianapolis, Indiana since inception. Allison trades on the New York Stock Exchange under the symbol, “ALSN”.
The Company has a global presence by serving customers in North America, Asia, Europe, South America, and Africa, with approximately 77% of its revenues being generated in North America in 2024. The Company serves customers through an independent network of approximately 1,600 inde pendent distributor and dealer locations worldwide.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The information herein reflects all normal recurring material adjustments, which are, in the opinion of management, necessary for a fair statement of the results for the periods presented. The consolidated financial statements herein consist of all wholly-owned domestic and foreign subsidiaries with all significant intercompany transactions eliminated.
These consolidated financial statements present the financial position, results of comprehensive income, cash flows and statements of stockholders’ equity.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses. Estimates include, but are not limited to, sales incentives, government price adjustments, fair market values and future cash flows associated with goodwill, indefinite-lived intangibles, definite-lived intangibles, long-lived asset impairment tests, useful lives for depreciation and amortization, warranty liabilities, core deposit liabilities, determination of discount rate and other assumptions for pension and other post-retirement benefit (“OPEB”) expense, income taxes and deferred tax valuation allowances, derivative valuation, assumptions for business combinations and contingencies. The Company’s accounting policies involve the application of judgments and assumptions made by management that include inherent risks and uncertainties. Actual results could differ materially from these estimates and from the assumptions used in the preparation of the Company's financial statements. Changes in estimates are recorded in results of operations in the period that the events or circumstances giving rise to such changes occur.
Segment Reporting
In accordance with the Financial Accounting Standards Board’s (“FASB”) authoritative accounting guidance on segment reporting, the Company hasone operating segment and reportable segment. The Company is in one line of business, which is the manufacture and distribution of vehicle propulsion solutions.
Business Combinations
The Company uses the acquisition method to account for business combinations. The assets acquired and liabilities assumed are recorded at their respective estimated fair value at the date of acquisition. Any excess purchase price over the fair values of the acquired net assets is recorded as goodwill. Determining the fair values of assets acquired and liabilities assumed requires management's judgment and includes the use of estimates with respect to timing and amount of future cash flows, market rate assumptions, actuarial assumptions, appropriate discount rates and other relevant factors.
Cash and Cash Equivalents
Cash equivalents are defined as short-term, highly-liquid investments with original maturities of 90 days or less. Under the Company’s cash management system, checks issued but not presented to banks may result in book overdraft balances for accounting purposes and are classified within Accounts payable in the Consolidated Balance Sheets. The change in book overdrafts is reported as a component of operating cash flows for Accounts payable.
Investments
Investments in equity securities where the Company is able to exercise significant influence, but not control, are accounted for under the equity method. Significant influence is typically considered to exist when the Company's ownership interest in the investee is between 20% and 50%, although other factors, such as representation on the investee's board of directors and the impact of commercial arrangements, also are considered. Investments in limited partnerships and limited liability companies are also accounted for using the equity method if the Company's investment is more than minor or if the Company is the general partner. Under the equity method of accounting, the investment is initially recorded at cost and subsequently adjusted by the Company's proportionate share of the entity's net income, with adjustments recognized in Other (expense) income, net.
Investments in equity securities with a readily determinable fair value, not accounted for under the equity method, are recorded at fair value with unrealized gains and losses included in Other (expense) income, net. For equity securities without a readily determinable fair value, the investments are recorded utilizing the measurement alternative at cost, less any impairment, plus or minus adjustments related to observable transactions for the same or similar securities, with gains and losses included in Other (expense) income, net. See "Note 7. Fair Value of Financial Instruments" for more details on the Company's investments in equity securities.
Inventories
Inventories are stated at the lower of cost or net realizable value. The Company determines cost using the first-in, first-out method. The Company analyzes inventory on a quarterly basis to determine whether it is excess or obsolete inventory. Any decline in carrying value of estimated excess or obsolete inventory is recorded as a reduction of inventory and as an expense included in Cost of sales in the period it is identified.
Property, Plant and Equipment
Property, plant and equipment are recorded at cost less accumulated depreciation. Depreciation expense is recorded using the straight-line method over the following estimated lives:
| Range inYears | |
|---|---|
| Land improvements | 5 – 30 |
| Buildings and building improvements | 10 – 40 |
| Machinery and equipment | 2 – 20 |
| Software | 2 – 5 |
| Special tooling | 2 – 10 |
Software represents the costs of software developed or obtained for internal use. Software costs are amortized on a straight-line basis over their estimated useful lives. Software assets are reviewed for impairment when events or circumstances indicate that the carrying value may not be recoverable over the remaining lives of the assets. Upgrades and enhancements are capitalized if they result in added functionality, which enables the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion and business process reengineering costs are expensed in the period in which they are incurred.
Special tooling represents the costs to design and develop tools, dies, jigs and other items owned by the Company and used in the manufacture of components by suppliers under long-term supply agreements. Special tooling is depreciated on a straight-line basis over the tool’s expected useful life. Special tooling used in the development of new technology is expensed as incurred. Engineering, testing and other costs incurred in the design and development of production parts are expensed as incurred.
Impairment of Long-Lived Assets
The carrying value of long-lived assets is evaluated whenever events or circumstances indicate that the carrying value of an asset may not be recoverable. Events or circumstances that would result in an impairment review primarily include a significant change in the use of an asset or the planned sale or disposal of an asset. The asset would be considered impaired when there is no future use planned for the asset or the future net undiscounted cash flows generated by the asset or asset group are less than its carrying value. An impairment loss would be recognized based on the amount by which the carrying value exceeds fair value.
Assumptions and estimates used to determine cash flows in the evaluation of impairment and the fair values used to determine the impairment are subject to a degree of judgment and complexity. Any changes to the assumptions and estimates resulting from changes in actual results or market conditions from those anticipated may affect the carrying value of long-lived assets and could result in an impairment charge.
Goodwill and Other Intangible Assets
The Company has elected to perform its annual impairment tests for goodwill and indefinite-lived intangible assets on October 31 of every year using a multi-step impairment test. In Step 0, the Company has the option to evaluate various qualitative factors to determine the likelihood of impairment. If the Company determines that the fair value is more likely than not less than the carrying value, then it is required to perform Step 1. If the Company does not elect to perform Step 0, it can voluntarily proceed directly to Step 1. In Step 1, the Company performs a quantitative analysis to compare the fair value to its carrying value. If the fair value exceeds the carrying value, no impairment is recorded, and the Company is not required to perform further testing. If the carrying value exceeds fair value, the Company would record an impairment loss equal to the difference.
A qualitative assessment contains uncertainties because it requires management to make assumptions and to apply judgment to assess business changes, economic outlook, financial trends and forecasts, growth rates, credit ratings, equity ratings, discount rates, industry data and other relevant qualitative factors.
A quantitative analysis contains uncertainties because it is performed utilizing a discounted cash flow model which includes key assumptions, such as financial forecasts; net sales growth derived from market information, industry reports, marketing programs and future new product introductions; operating margin improvements derived from cost reduction programs and fixed cost leverage driven by higher sales volumes; and a risk-adjusted discount rate.
Goodwill represents the excess of purchase price paid over the fair value of net assets acquired. In accordance with the FASB’s authoritative accounting guidance on goodwill, the Company does not amortize goodwill but rather evaluates it for impairment on an annual basis, or more often if events or circumstances change that could cause goodwill to become impaired. Goodwill is tested for impairment at the reporting unit level, which is the same as the Company's one operating and reportable segment. The Company does not aggregate any components into its reporting unit.
Goodwill impairment testing for 2024 was performed using the Step 0 analysis by assessing certain qualitative trends and factors. These trends and factors were compared to, and based on, the assumptions used in prior years. After reviewing the various qualitative factors mentioned above, the Company's 2024 annual goodwill impairment test indicated that the fair value for the reporting unit more likely than not exceeded its carrying value, indicatingno impairment.
Other intangible assets have both indefinite and finite useful lives. Intangible assets with indefinite useful lives are not amortized but are tested annually for impairment, or more often if events or circumstances change that could cause intangible assets with indefinite useful lives to become impaired. After reviewing the various qualitative factors mentioned above, the Company's annual 2024 indefinite-lived intangible assets impairment tests, as of October 31, 2024, indicated that the fair value of its indefinite-lived intangible assets more likely than not exceeded their respective carrying value, indicating no impairment.
Intangible assets with finite lives are amortized over their estimated useful lives and reviewed for impairment when circumstances change that would create a triggering event. Customer relationships are amortized over the life in which expected benefits are to be consumed. The other remaining finite life intangibles are amortized on a straight-line basis over their useful lives. The Company evaluates the remaining useful life of the other intangible assets on a periodic basis to determine whether events or circumstances warrant a revision to the remaining useful life. Assumptions and estimates about future values and remaining useful lives of the Company's intangible and other long-lived assets are complex and subjective. Such assumptions and estimates can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors, such as changes in the Company's business strategy and internal forecasts. Although management believes the historical assumptions and estimates are reasonable and appropriate, different assumptions and estimates could materially impact the Company's reported financial results. Further information is provided in "Note 6. Goodwill and Other Intangible Assets.”
Deferred Financing Costs
The deferred financing costs related to line-of-credit arrangements are presented as a component of other non-current assets. The deferred financing costs related to other types of debt instruments such as notes and loans are presented as a component of long-term debt. Deferred financing costs continue to be amortized over the life of the related debt using the effective interest method. Amortization of deferred financing costs is recorded as part of interest expense and totaled $3 million for the year ended December 31, 2024 and $4 million for each of the years ended December 31, 2023 and 2022.
Financial Instruments
The Company’s cash equivalents are invested in U.S. government backed securities and recorded at fair value in the Consolidated Balance Sheets. The Company's marketable securities are carried at fair value on the Consolidated Balance Sheets. The Company’s financial derivative instruments, including interest rate swaps, are carried at fair value on the Consolidated Balance Sheets. Refer to "Note 7. Fair Value of Financial Instruments” for more detail. The Company’s long-term debt obligations are carried at historical amounts with the Company providing fair value disclosure in "Note 8. Debt”. The carrying values of accounts receivable and accounts payable approximate fair value due to their short-term nature.
Insurable Liabilities
The Company records liabilities for its medical, workers’ compensation, long-term disability, product, general and auto liabilities. The determination of these liabilities and related expenses is dependent on claims experience. For most of these liabilities, claims incurred but not yet reported are estimated based upon historical claims experience.
Revenue Recognition
The Company records sales as each distinct performance obligation within a contract is satisfied. The Company sells extended transmission coverage (“ETC”) for which sales are deferred. ETC sales are recognized ratably over the period of coverage, which typically ranges fromone to five years after the standard warranty coverage ends. Costs associated with ETC programs are recorded as incurred during the extended period. Distributor and customer sales incentives, consisting of allowances and other rebates, are recorded as a reduction to Net sales when it is determined that the adjustment is not likely to reverse, historically on a quarterly basis. Incentive programs are generally product specific or region specific. Some factors used in estimating when an adjustment is not likely to reverse are the number of transmissions that will be affected by the incentive program and rate of acceptance of any incentive program.
Sales under U.S. government production contracts are recognized at the point in time when control passes to the customer, or when the U.S. government accepts the transmission and is able to direct its use in certain bill-and-hold arrangements. Deferred revenue arises from cash received in advance of the culmination of the earnings process and is recognized as revenue in future periods when the applicable revenue recognition criteria have been met. Under the terms of certain previous U.S. government contracts, there were certain price reduction clauses and provisions for potential price reductions which were estimated at the time of sale based upon the Company’s history and experience and were recorded as a reduction to Net sales. Potential reductions may be attributed to a change in projected sales volumes or plant efficiencies which impact overall costs. The Company had $54 million recorded in the price reduction reserve account as of both December 31, 2024 and 2023.
The Company engages in licensing agreements with certain third parties for the use of the Company’s intellectual property. Deferred revenue arises from cash received in advance of the period of use of the intellectual property. Revenue is recognized over the license period as it is earned.
The Company classifies shipping and handling billed to customers in Net sales and shipping and handling costs in Cost of sales.
The Company contracts with various third parties to provide engineering services. These services are recorded as Net sales in accordance with the terms of the contract. The saleable engineering services recorded were $10 million, $26 million and $21 million for the years ended December 31, 2024, 2023 and 2022, respectively. The associated costs are recorded in Cost of sales.
Warranty
Provisions for estimated expenses related to product warranties are made at the time products are sold. Warranty claims arise when a transmission or propulsion solution manufactured by us fails while in service during the relevant warranty period. The warranty reserve is adjusted in Selling, general and administrative expense based on the Company’s current and historical warranty claims paid and associated repair costs. These estimates are established using historical information including the nature, frequency, and average cost of warranty claims and are adjusted as actual information becomes available. From time to time, the Company may initiate a specific field action program. As a result of the uncertainty surrounding the nature and frequency of specific field action programs, the liability for such programs is recorded when the Company commits to an action. The Company reviews and assesses the liability for these programs on a quarterly basis. The Company also assesses its ability to recover certain costs from its suppliers and records a receivable from the supplier when it believes a recovery is probable. Warranty costs may differ from those estimated if actual claim rates are higher or lower than the Company's historical rates.
Research and Development
The Company incurs costs in connection with research and development programs that are expected to contribute to future earnings. Such costs are charged to Engineering — research and development as incurred.
Foreign Currency Translation
Most of the Company’s subsidiaries outside the United States prepare financial statements in currencies other than the U.S. Dollar. The functional currency for all of these subsidiaries is the local currency, except for the Company’s Hong Kong and Middle East subsidiaries which currently use the U.S. Dollar as their functional currency. Balances are translated at period-end exchange rates for assets and liabilities and monthly weighted-average exchange rates for revenues and expenses. The translation gains and losses are stated as a component of Accumulated Other Comprehensive Loss (“AOCL”) as disclosed in "Note 17. Accumulated Other Comprehensive Loss”.
Derivative Instruments
In the normal course of business, the Company is exposed to fluctuations in interest rates, foreign currency exchange rates, and commodity prices. The risk is managed through the use of financial derivative instruments, when appropriate. The Company has qualified for and elected hedge accounting treatment on interest rate swap contracts. As necessary, the Company adjusts the values of the derivative instruments for counter-party or credit risk. "Note 9. Derivatives” provides further information on the accounting treatment of the Company’s derivative instruments.
Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. The future tax benefits associated with operating loss and tax credit carryforwards are recognized as deferred tax assets. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. When releasing income tax effects from AOCL, the Company utilizes the portfolio securities approach.
The need to establish a valuation allowance against the deferred tax assets is assessed periodically based on a more-likely-than-not realization threshold, in accordance with the FASB’s authoritative accounting guidance on income taxes. Appropriate consideration is given to all positive and negative evidence related to that realization. This assessment considers, among other matters, the nature, frequency and severity of recent losses, forecasts of future profitability, the duration of statutory carryforward periods, experience with tax attributes expiring unused and tax planning alternatives. The weight given to these considerations depends upon the degree to which they can be objectively verified.
The Company records uncertain tax positions on the basis of a two-step process whereby (1) it is determined whether it is more likely than not that the tax position will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority.
Stock-Based Compensation
In February 2024, the Company’s Board of Directors adopted, and in May 2024, the Company’s stockholders approved, the Allison Transmission Holdings, Inc. 2024 Equity Incentive Award Plan (“2024 Plan”), which became effective on May 8, 2024. The 2024 Plan was an amendment and restatement of the Allison Transmission Holdings, Inc. 2015 Equity Incentive Award Plan (the “Prior Plan”). Under the 2024 Plan, certain employees (including executive officers), consultants and directors are eligible to receive equity-based compensation, including non-qualified stock options, incentive stock options, restricted stock, dividend equivalents, stock payments, restricted stock units (“RSUs”), performance awards, stock appreciation rights and other equity-based awards, or any combination thereof. The 2024 Plan limits the aggregate number of shares of common stock available for issue to 3,850,000 and will expire on, and no option or other equity award may be granted pursuant to the 2024 Plan after, the tenth anniversary of the date the 2024 Plan was approved by the Board of Directors.
Prior to the adoption of the 2024 Plan, the Company’s equity-based awards were granted under the Prior Plan. As of the effective date of the 2024 Plan, no new awards will be granted under the Prior Plan, but the Prior Plan will continue to govern the equity awards issued under the Prior Plan.
RSU grants are recorded at fair market value at the date of grant and vest upon continued performance of services by the RSU holder typically overone tothree years. Perfo rmance unit grants are recorded at fair value based on a Monte-Carlo pricing model, and the restrictions lapse on the date the Compensation Committee of the Board of Directors determines the number of shares that shall vest based on the related performance or market condition achievement. Non-qualified stock option grants are recorded at fair value using a Black-Scholes option pricing model and vest upon the continued performance of services by the option holder typically overone to three years.
The Company has made a policy election under applicable accounting guidance to account for forfeitures as a reduction of stock-based compensation expense when the forfeiture actually occurs.
RSUs were granted to certain employees and directors at fair market value on the date of grant. The restrictions lapse upon continued performance by the RSU holder on the vest date which generally occurs overone, two orthree years. RSU incentive compensation expense recorded was $13 million, $11 million and $9 million for the years ended December 31, 2024, 2023 and 2022, respectively.
Performance-based awards, including performance units, were granted to certain employees at fair value at the date of grant. The Company records the fair value of each performance-based award based on a Monte-Carlo pricing model. Performance-based award incentive compensation expense recorded was $6 million for the year ended of December 31, 2024 and $5 for each of the years ended December 31, 2023 and 2022.
Stock options were granted to certain employees at fair value on the date of grant using a Black-Scholes option pricing model. Stock option incentive compensation expense recorded was $7 million, $6 million and $4 million for the years ended December 31,2024, 2023 and 2022, respectively.
Pension and Post-retirement Benefit Plans
For pension and OPEB plans in which employees participate, costs are determined within the FASB’s authoritative accounting guidance set forth in employers’ defined benefit pensions including accounting for settlements and curtailments of defined benefit pension plans, termination of benefits and accounting for post-retirement benefits other than pensions. In accordance with the authoritative accounting guidance, the Company recognizes the funded status of its defined benefit pension plans and OPEB plan in its Consolidated Balance Sheets with a corresponding adjustment to AOCL, net of tax.
Post-retirement benefit costs consist of service cost and interest cost on accrued obligations. Actuarial gains and losses on liabilities, together with any prior service costs, are charged (or credited) to income over the average remaining service lives of employees.
The benefit cost components shown in the Consolidated Statements of Comprehensive Income are based upon various actuarial assumptions and methodologies as prescribed by authoritative accounting guidance. These assumptions include discount rates, expected return on plan assets, health care cost trend rates, inflation, rate of compensation increases, population demographics, mortality rates and other factors. The Company reviews all actuarial assumptions on an annual basis. Changes in key economic indicators can change these assumptions. These assumptions, along with the actual value of assets at the measurement date, will impact the calculation of pension expenses for the following year.
Recently Adopted Accounting Pronouncements
In November 2023, the FASB issued authoritative accounting guidance expanding public entities’ reportable segment disclosures, primarily through enhanced disclosures about significant segment expenses that are regularly reviewed by the Chief Operating Decision Maker ("CODM") and included within each reported measure of segment profit or loss. The Company adopted this guidance during the year ended December 31, 2024. The adoption of this guidance did not have an impact on the Company's consolidated financial statements but resulted in additional disclosures. See "Note 23. Segment Information" for further details.
Recently Issued Accounting Pronouncements
In December 2023, the FASB issued authoritative accounting guidance to improve income tax disclosures by requiring disaggregated information about a reporting entity's effective tax rate reconciliation and information on income taxes paid. The guidance will become effective for the Company beginning with its fiscal year ended December 31, 2025. The guidance will be applied prospectively with the option to apply it retrospectively. Management is currently evaluating the impact of this guidance on the Company's consolidated financial statements.
In November 2024, the FASB issued authoritative accounting guidance to require additional disaggregation of certain expense and cost line items presented in the financial statements and in the notes to the financial statements. The guidance will become effective for the Company beginning with the fiscal year ended December 31, 2027 and the subsequent interim periods. Early adoption is permitted. Upon adoption, the guidance may be applied prospectively or retrospectively. Management is currently evaluating the impact of this guidance on the Company's consolidated financial statements.
All other recently issued accounting pronouncements were assessed as either not applicable to the Company or were not expected to have a material impact on the Company's consolidated financial statements.
NOTE 3. REVENUE
Revenue is recognized as each distinct performance obligation within a contract is satisfied. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. The Company enters into long-term agreements (“LTAs”) and distributor agreements with certain customers. The LTAs and distributor agreements do not include committed volumes until underlying purchase orders are issued; therefore, the Company determined that purchase orders are the contract with a customer. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when the performance obligation is satisfied, as there is no right of return.
Some of the Company's contracts include multiple performance obligations, most commonly the sale of both a transmission and ETC. The Company allocates the contract’s transaction price to each performance obligation based on the standalone selling price of each distinct good or service in the contract.
The Company may also use volume-based discounts and rebates as marketing incentives in the sales of both vehicle propulsion solutions and service parts, which are accounted for as variable consideration. The Company records the impact of the incentives as a reduction to revenue when it is determined that the adjustment is not likely to reverse. The Company estimates the impact of all other incentives based on the related sales and market conditions in the end market vocation. The Company recordedno material adjustments based on variable consideration during any of the years ended December 31, 2024, 2023 and 2022.
Net sales are made on credit terms, generally 30 days, based on an assessment of the customer’s creditworthiness. For certain goods or services, the Company receives consideration prior to satisfying the related performance obligation. Such consideration is recorded as a contract liability in current and non-current deferred revenue as of December 31, 2024 and December 31, 2023. See "Note 11. Deferred Revenue” for more information including the amount of revenue earned during the year ended December 31, 2024 that had been previously deferred. The Company hadno material contract assets as of either December 31, 2024 or 2023.
The Company hasone operating segment and reportable segment. The Company is in one line of business, which is the design, manufacture and distribution of vehicle propulsion solutions. The following presents disaggregated revenue by categories that best depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors (dollars in millions):
| Year endedDecember 31,2024 | Year endedDecember 31,2023 | Year endedDecember 31,2022 | |
|---|---|---|---|
| North America On-Highway | $1,752 | $1,529 | $1,359 |
| North America Off-Highway | 8 | 63 | 86 |
| Defense | 212 | 166 | 146 |
| Outside North America On-Highway | 493 | 477 | 463 |
| Outside North America Off-Highway | 97 | 104 | 127 |
| Service Parts, Support Equipment and Other | 663 | 696 | 588 |
| Total Net Sales | $3,225 | $3,035 | $2,769 |
Disaggregated revenue by end market is further described as follows:
North America On-Highway
Revenue from the North America On-Highway end market is driven by the sale of propulsion solutions to original equipment manufacturers (“OEMs”), distributors and dealers that install the product into Class 4-5, Class 6-7 and Class 8 straight trucks, Class 8 day cab tractors, conventional transit, shuttle and coach buses, school buses and motorhome applications. Revenue is recognized at the point in time when control passes to the customer, which is based on shipping terms when the order is fulfilled by the Company.
North America Off-Highway
Revenue from the North America Off-Highway end market is driven by sales of transmissions to OEMs and distributors that serve end users who operate vehicles and auxiliary equipment in energy, mining and construction applications. Revenue is recognized at the point in time when control passes to the customer, which is based on shipping terms when the order is fulfilled by the Company.
Defense
Revenue from the Defense end market is driven by sales of propulsion solutions to the U.S. Government or its contractors and sales to certain government contractors outside of the U.S. for use in both wheeled and tracked defense vehicle applications. Revenue is recognized at the point in time when control passes to the customer, which is based on shipping terms when the order is fulfilled by the Company.
Periodically, the Company and the U.S. Government will enter into a bill-and-hold arrangement where a completed transmission physically remains at the Company’s facility at the request of the U.S. Government. Revenue is recognized at the point in time when it is determined that the U.S. Government accepts the transmission and is able to direct its use.
Outside North America On-Highway
Revenue from the Outside North America On-Highway end market is driven by the sale of propulsion solutions to OEMs and distributors that produce vehicles for commercial users in medium- and heavy-duty applications and wheeled defense platforms. Revenue is recognized at the point in time when control passes to the customer, which is based on shipping terms when the order is fulfilled by the Company.
Outside North America Off-Highway
Revenue from the Outside North America Off-Highway end market is driven by sales of transmissions to OEMs and distributors serving end users who operate vehicles and auxiliary equipment in energy, mining and construction applications. Revenue is recognized at the point in time when control passes to the customer, which is based on shipping terms when the order is fulfilled by the Company.
Service Parts, Support Equipment and Other
Revenue from the Service Parts, Support Equipment and Other end market is primarily derived from the sale of transmission parts and fluid purchased for the normal maintenance and repair needs of products in service, the sale of aluminum die cast components purchased as original parts and the sale of ETC contracts which extend the warranty coverages of propulsion solutions beyond the standard warranty period.
Revenue is recognized on sales of service parts, support equipment and aluminum die cast components at the point in time when control passes to the customer, which is based on shipping terms when the order is fulfilled by the Company.
Revenue from the sale of ETC contracts is recognized ratably over the time period that corresponds with the period of coverage, as the Company has determined this method best depicts the progress towards satisfaction of its performance obligation. ETC contracts are typically sold in one to five year durations within the North America On-Highway, Outside North America On-Highway, North America Off-Highway and Outside North America Off-Highway end markets. The ETC contract period begins when the standard warranty coverage period ends. All consideration allocated to an ETC performance obligation is initially deferred until the coverage period begins.
NOTE 4. INVENTORIES
Inventories consisted of the following components (dollars in millions):
| December 31, 2024 | December 31, 2023 | |
|---|---|---|
| Purchased parts and raw materials | $162 | $152 |
| Work in progress | 17 | 17 |
| Finished goods | 79 | 53 |
| Service parts | 57 | 54 |
| Total inventories | $315 | $276 |
Inventory components shipped to third parties, primarily cores, parts to re-manufacturers, and parts to contract manufacturers, which the Company has an obligation to buy back, are included in purchased parts and raw materials, with an offsetting liability in Other current liabilities. See "Note 14. Other Current Liabilities” for more information.
NOTE 5. PROPERTY, PLANT AND EQUIPMENT
The cost and accumulated depreciation of property, plant and equipment are as follows(dollars in millions):
| December 31, 2024 | December 31, 2023 | |
|---|---|---|
| Machinery and equipment | $1,003 | $937 |
| Buildings and building improvements | 537 | 528 |
| Special tooling | 239 | 259 |
| Software | 200 | 195 |
| Construction in progress | 73 | 68 |
| Land and land improvements | 28 | 29 |
| Total property, plant and equipment | 2,080 | 2,016 |
| Accumulated depreciation | (1,277) | (1,242) |
| Property, plant and equipment, net | $803 | $774 |
Depreciation of property, plant and equipment was $111 million, $109 million and $109 million for the years ended December 31,2024, 2023 and 2022, respectively.
NOTE 6. GOODWILL AND OTHER INTANGIBLE ASSETS
As of December 31, 2024 and 2023, the carrying amount of the Company’s Goodwill was $2,075 million and $2,076 million, respectively.
The following presents a summary of other intangible assets (dollars in millions):
| December 31, 2024 | December 31, 2023 | |||||
|---|---|---|---|---|---|---|
| Intangibleassets, gross | Accumulatedamortization | Intangibleassets, net | Intangibleassets, gross | Accumulatedamortization | Intangibleassets, net | |
| Other intangible assets: | ||||||
| Trade name | $791 | $— | $791 | $791 | $— | $791 |
| In-process research and development | — | — | — | 25 | — | 25 |
| Customer relationships – commercial | 839 | (837) | 2 | 839 | (833) | 6 |
| Proprietary technology | 507 | (481) | 26 | 484 | (479) | 5 |
| Customer relationships – defense | 62 | (59) | 3 | 62 | (56) | 6 |
| Non-compete agreement | 1 | (1) | — | 1 | (1) | — |
| Total | $2,200 | $(1,378) | $822 | $2,202 | $(1,369) | $833 |
In the second quarter of 2024, the Company reclassified $23 million of in-process research and development ("IPR&D") to Proprietary technology. The IPR&D was reclassified upon the completion of the Company's project to develop commercially viable eGen Power products.
Amortization of intangible assets was $10 million, $45 million and $46 million for the years ended December 31, 2024, 2023 and 2022, respectively.
The Company’s 2024 annual goodwill impairment test indicated that the fair value of the reporting unit more likely than not exceeded its carrying value, indicatingno impairment. The Company's 2024 annual indefinite-lived intangible assets impairment test indicated that the fair value of the Company’s indefinite-lived intangible assets more likely than not exceeded their carrying value, indicatingno impairment.
Amortization expense related to other intangible assets for the next five years is expected to be (dollars in millions):
| 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|
| Amortization expense | $7 | $3 | $3 | $2 | $2 |
NOTE 7. FAIR VALUE OF FINANCIAL INSTRUMENTS
Fair value is the price (exit price) that would be received to sell an asset or paid to transfer a liability in an orderly tran saction between market participants at the measurement date. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The accounting guidance establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy defined by the relevant guidance are as follows:
Level 1 — Quoted prices are available in active markets for identical assets or liabilities as of the reporting date.
Level 2 — Inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 2 includes financial instruments that are valued using quoted prices in markets that are not active and those financial instruments that are valued using models or other valuation methodologies in which all significant value-drivers are observable in active markets or are supported by observable levels at which transactions are executed in the marketplace.
Level 3 — Certain inputs are unobservable or have little or no market data available. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. At each balance sheet date, the Company performs an analysis of all instruments subject to authoritative accounting guidance and includes, in Level 3, all of those whose fair value is based on significant unobservable inputs. As of December 31, 2024 and 2023, the Company didnot have any Level 3 financial assets or liabilities.
The Company’s assets and liabilities that are measured at fair value include cash equivalents, marketable securities, derivative instruments, assets held in a rabbi trust and a deferred compensation obligation. The Company’s cash equivalents consist of short-term U.S. government backed securities and time deposits. The Company's marketable securities consist of publicly traded stock of Jing-Jin Electric Technologies Co. Ltd., which has a readily determinable fair value. The Company’s derivative instruments consist of interest rate swaps. The Company’s assets held in the rabbi trust consist principally of publicly available mutual funds and target date retirement funds. The Company’s deferred compensation obligation is directly related to the fair value of assets held in the rabbi trust.
The Company’s valuation techniques used to calculate the fair value of cash equivalents, marketable securities, assets held in the rabbi trust and the deferred compensation obligation represent a market approach in active markets for identical assets that qualify as Level 1 in the fair value hierarchy.
The Company’s valuation techniques used to calculate the fair value of derivative instruments represent a market approach with observable inputs that qualify as Level 2 in the fair value hierarchy. The Company uses valuations from the issuing financial institutions for the fair value measurement of interest rate swaps. The floating-to-fixed interest rate swaps are based on the Secured Overnight Financing Rate ("SOFR"), which is observable at commonly quoted intervals. The fair values are included in other current and non-current assets in the Consolidated Balance Sheets. See “Note 9. Derivatives” for more information regarding the Company’s interest rate swaps.
The following table summarizes the fair value of the Company’s financial assets and (liabilities) as of December 31,2024 and 2023 (dollars in millions):
| Fair Value Measurements Using | ||||||
|---|---|---|---|---|---|---|
| Quoted Prices in ActiveMarkets for IdenticalAssets (Level 1) | Significant OtherObservable Inputs(Level 2) | TOTAL | ||||
| 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | |
| Cash equivalents | $664 | $421 | $— | $— | $664 | $421 |
| Marketable securities | 11 | 20 | — | — | 11 | 20 |
| Rabbi trust assets | 20 | 18 | — | — | 20 | 18 |
| Deferred compensation obligation | (20) | (18) | — | — | (20) | (18) |
| Derivative assets | — | — | 5 | 12 | 5 | 12 |
| Total | $675 | $441 | $5 | $12 | $680 | $453 |
The Company holds equity securities in unconsolidated entities without a readily determinable fair value. Each of these investments represents a less than 20% ownership interest in the respective privately-held entity, and the Company does not maintain significant influence over or control of any of the entities. The Company has elected the measurement alternative and measures the investments at cost, less any impairment, plus or minus adjustments related to observable price changes in orderly transactions for identical or similar investments of the same issuer. These equity investments are recorded in Other non-current assets in the Consolidated Balance Sheets, with changes in the value recorded in Other (expense) income, net in the Consolidated Statements of Comprehensive Income. During the year ended December 31, 2024, no impairment charges or adjustments resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer occurred for any of these investments. As of December 31, 2024 and 2023, the Company held equity securities without a readily determinable fair value of $7 million and $5 million, respectively.
NOTE 8. DEBT
Long-term debt and maturities are as follows (dollars in millions):
| December 31, 2024 | December 31, 2023 | |
|---|---|---|
| Long-term debt: | ||
| Senior Secured Credit Facility Term Loan, variable, due 2026 | $— | $618 |
| Senior Notes, fixed 4.75%, due 2027 | 400 | 400 |
| Senior Notes, fixed 5.875%, due 2029 | 500 | 500 |
| Senior Notes, fixed 3.75%, due 2031 | 1,000 | 1,000 |
| Senior Secured Credit Facility Term Loan, variable, due 2031 | 514 | — |
| Total long-term debt | $2,414 | $2,518 |
| Less: current maturities of long-term debt | 5 | 6 |
| deferred financing costs, net (see Note 2) | 14 | 15 |
| Total long-term debt, net | $2,395 | $2,497 |
Principal payments required on long-term debt during the next five years are as follows (dollars in millions):
| 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|
| Payments | $5 | $5 | $405 | $5 | $505 |
As of December 31, 2024, the Company had $2,414 million of indebtedness associated with Allison Transmission, Inc.’s (“ATI”), the Company’s wholly-owned subsidiary,4.75% Senior Notes due October 2027 (“4.75% Senior Notes”), ATI’s 5.875% Senior Notes due June 2029 (“5.875% Senior Notes”), ATI’s 3.75% Senior Notes due January 2031 (“3.75% Senior Notes” and, together with the 4.75% Senior Notes and 5.875% Senior Notes, the “Senior Notes”) and the Second Amended and Restated Credit Agreement dated as of March 29, 2019, as amended (the “Credit Agreement”), governing ATI’s term loan facility in the amount of $514 million due March 2031 (“Term Loan”) and ATI’s revolving credit facility with commitments in the amount of $750 million due March 2029 (“Revolving Credit Facility” and, together with the Term Loan, the “Senior Secured Credit Facility”).
The fair value of the Company’s long-term debt obligations as of December 31, 2024 was $2,286 million. The fair value is based on quoted Level 2 market prices of the Company’s debt as of December 31, 2024. The difference between the fair value and carrying value of the long-term debt is driven primarily by trends in the financial markets.
Senior Secured Credit Facility
In March 2024, the Company and ATI entered into Amendment No. 4 ("Amendment") to the Credit Agreement, after giving effect to a $101 million principal prepayment, to remove the 0.10% credit spread adjustment to the SOFR benchmark for all available interest periods and increase the commitments under the existing Revolving Credit Facility by $100 million. The Amendment also extended the maturity date of the existing Term Loan from 2026 to 2031 and extended the existing Revolving Credit Facility termination date from 2025 to 2029. With the exception of the items noted above, the terms of the extended Term Loan and Revolving Credit Facility are materially the same as they were prior to the Amendment. The Amendment was treated as a modification to the Senior Secured Credit Facility under GAAP. The Company recorded $4 million as new deferred financing fees in the Consolidated Balance Sheet as of December 31, 2024 and expensed $1 million of prior deferred financing fees in the Consolidated Statement of Comprehensive Income for the year ended December 31, 2024.
The borrowings under the Senior Secured Credit Facility are collateralized by a lien on substantially all assets of the Company, ATI and certain existing and future U.S. subsidiary guarantors, as provided in the Credit Agreement. Interest on the Term Loan, as of December 31, 2024, is either (a)1.75% over a SOFR rate on deposits in U.S. dollars for one-, three- or six-month periods (or a twelve-month period if, at the time of the borrowing, consented to by all relevant lenders and the administrative agent) ("Term SOFR"), or (b)0.75% over the greater of the prime lending rate as quoted by the administrative agent, the Term SOFR rate for an interest period of one month plus 1.00% and the federal funds effective rate published by the Federal Reserve Bank of New York plus 0.50%, subject to a 1.00% floor (the "Base Rate"). As of December 31,2024, the Company elected to pay the lowest all-in rate of Term SOFR plus the applicable margin, or 6.19%, on the Term Loan. The Credit Agreement requires minimum quarterly principal payments on the Term Loan, as well as prepayments from certain net cash proceeds of non-ordinary course asset sales and casualty and condemnation events, the incurrenceof certain debt and from a percentage of excess cash flow, if applicable. The minimum required quarterly principal payment on the Term Loan through its maturity date of March 2031 is $1 million. As of December 31,2024, there had been no payments required for certain net cash proceeds of non-ordinary course asset sales and casualty and condemnation events. The remaining principal balance is due upon maturity.
The Senior Secured Credit Facility also provides a Revolving Credit Facility, net of an allowance for up to $75 million in outstanding letters of credit commitments. Throughout the year ended December 31,2024, the Company madeno withdrawals on the Revolving Credit Facility. As of December 31,2024, the Company had $744 million available under the Revolving Credit Facility, net of $6 million in letters of credit. Borrowings under the Revolving Credit Facility bear interest at a variable base rate plus an applicable margin based on the Company’s first lien net leverage ratio. When the Company’s first lien net leverage ratio is above 4.00 x, interest on the Revolving Credit Facility is (a)0.75% over the Base Rate or (b)1.75% over the Term SOFR rate; when the Company’s first lien net leverage ratio is equal to or less than 4.00 x and above 3.50 x, interest on the Revolving Credit Facility is (i)0.50% over the Base Rate or (ii)1.50% over the Term SOFR rate; and when the Company’s first lien net leverage ratio is equal to or below 3.50 x, interest on the Revolving Credit Facility is (y)0.25% over the Base Rate or (z)1.25% over the Term SOFR rate. As of December 31,2024, the applicable margin for the Revolving Credit Facility was 1.25%. In addition, there is an annual commitment fee, based on the Company’s first lien net leverage ratio, on the average unused revolving credit borrowings available under the Revolving Credit Facility. As of December 31, 2024, the commitment fee was 0.25%. Borrowings under the Revolving Credit Facility are payable at the option of the Company throughout the term of the Revolving Credit Facility with the balance due in March 2029.
The Senior Secured Credit Facility requires the Company to maintain a specified maximum first lien net leverage ratio of 5.50 x when revolving loan commitments remain outstanding on the Revolving Credit Facility at the end of a fiscal quarter. As of December 31, 2024, the Company hadno amounts outstanding under the Revolving Credit Facility; however, the Company would have been in compliance with the maximum first lien net leverage ratio, achieving a(0.23 x) ratio. Additionally, within the terms of the Senior Secured Credit Facility, a first lien net leverage ratio at or below 4.00 x results in the elimination of excess cash flow payments on the Senior Secured Credit Facility for the applicable year.
In addition, the Credit Agreement, among other things, includes customary restrictions (subject to certain exceptions) on the Company’s ability to incur certain indebtedness, grant certain liens, make certain investments, engage in acquisitions, consolidations and mergers, declare or pay certain dividends or repurchase shares of the Company’s common stock. As of December 31, 2024, the Company was in compliance with all covenants under the Credit Agreement.
Senior Notes
Each series of the Senior Notes is unsecured and is guaranteed by each of ATI’s domestic subsidiaries that is a borrower under or guarantees the Senior Secured Credit Facility and is unconditionally guaranteed, jointly and severally, by any of ATI’s future domestic subsidiaries that are borrowers under or guarantee the Senior Secured Credit Facility. None of ATI’s domestic subsidiaries currently guarantee its obligations under the Senior Secured Credit Facility, and therefore none of ATI’s domestic subsidiaries currently guarantee any series of the Senior Notes. The indentures governing the Senior Notes contain negative covenants restricting or limiting the Company’s ability to, among other things: incur or guarantee additional indebtedness, incur liens, pay dividends on, redeem or repurchase the Company’s capital stock, make certain investments, permit payment or dividend restrictions on certain of the Company’s subsidiaries, sell assets, engage in certain transactions with affiliates, and consolidate or merge or sell all or substantially all of the Company’s assets. As of December 31, 2024, the Company was in compliance with all covenants under the indentures governing the Senior Notes.
ATI may from time to time seek to retire its Senior Notes through cash purchases, exchanges for equity securities, open market purchases, privately negotiated transactions, contractual redemptions or otherwise. Such repurchases or exchanges, if any, will depend on prevailing market conditions, liquidity requirements, contractual restrictions and other factors and will be in accordance with the respective indenture governing such notes. The amounts involved may be material. Some or all of the 4.75% Senior Notes and the 5.875% Senior Notes may be redeemed at any time at redemption prices specified in the indentures governing such notes. Prior to January 30, 2026, ATI may redeem some or all of the 3.75% Senior Notes by paying a price equal to 100.00% of the principal amount being redeemed, plus an “applicable premium”. At any time on or after January 30, 2026, ATI may redeem some or all of the 3.75% Senior Notes at redemption prices specified in the indenture governing such notes.
NOTE 9. DERIVATIVES
The Company is subject to interest rate risk related to the Senior Secured Credit Facility and entered into interest rate swaps to manage a portion of this exposure. The interest rate swaps are designated as cash flow hedges that qualify for hedge accounting under the hypothetical derivative method. During the first quarter of 2024, the Company and ATI entered into the Amendment to the Credit Agreement that changed critical terms of the hedged item. Therefore, the Company performed a quantitative assessment that demonstrated a highly effective hedging relationship that qualifies for hedge accounting under the hypothetical derivative method.
As of December 31, 2024, the Company held interest rate swap contracts that, in the aggregate, effectively hedge $500 million of the variable rate debt associated with the Term Loan at the Term SOFR weighted average fixed rate of 2.81% through September 2025.
Fair value adjustments are recorded as a component of AOCL in the Consolidated Balance Sheets. Balances in AOCL are reclassified to earnings when transactions related to the underlying risk are settled. See "Note 7. Fair Value of Financial Instruments” for information regarding the fair value of the Company’s interest rate swaps.
The following tabular disclosures further describe the Company’s interest rate derivatives qualifying and designated for hedge accounting and their impact on the financial condition of the Company (dollars in millions):
| Fair Value | |||
|---|---|---|---|
| Balance SheetLocation | December 31,2024 | December 31,2023 | |
| Derivative Assets: | |||
| Interest rate swaps | Other current assets | $5 | $7 |
| Other non-current assets | — | 5 | |
| Total derivative assets | $5 | $12 | |
The balance of net derivative gains recorded in AOCL as of December 31, 2024 and 2023 was $5 million and$12 million, respectively. As of December 31, 2024, all derivative gains recorded in AOCL are expected to be reclassified to earnings within the next twelve months. See "Note 17. Accumulated Other Comprehensive Loss” for information regarding activity recorded as a component of AOCL during the year ended December 31, 2024.
NOTE 10. PRODUCT WARRANTY LIABILITIES
As of December 31, 2024, the current and non-current product warranty liabilities were $31 million and $36 million, respectively. As of December 31, 2023, the current and non-current product warranty liabilities were $32 million and $27 million, respectively. Product warranty liability activities consisted of the following (dollars in millions):
| Year endedDecember 31,2024 | Year endedDecember 31,2023 | Year endedDecember 31,2022 | |
|---|---|---|---|
| Beginning balance | $59 | $57 | $53 |
| Payments | (41) | (41) | (31) |
| Increase in liability (warranty issued during period) | 33 | 28 | 17 |
| Net adjustments to liability | 16 | 15 | 18 |
| Ending balance | $67 | $59 | $57 |
The adjustments to the total liability in 2024, 2023 and 2022 were the result of general changes in estimates for various products and specific field action programs as additional claims data and field information became available.
NOTE 11. DEFERRED REVENUE
As of December 31, 2024, the current and non-current deferred revenue were $41 million and $95 million, respectively. As of December 31, 2023, the current and non-current deferred revenue were $41 million and $89 million, respectively. Deferred revenue activity consisted of the following (dollars in millions):
| Year endedDecember 31,2024 | Year endedDecember 31,2023 | Year endedDecember 31,2022 | |
|---|---|---|---|
| Beginning balance | $130 | $131 | $136 |
| Increases | 51 | 52 | 35 |
| Revenue earned | (45) | (53) | (40) |
| Ending balance | $136 | $130 | $131 |
Deferred revenue recorded in current and non-current liabilities related to ETC as of December 31, 2024 was $29 million and $95 million, respectively. Deferred revenue recorded in current and non-current liabilities related to ETC as of December 31, 2023 was $30 million and $85 million, respectively.
NOTE 12. LEASES
Lessee Accounting
Contracts are assessed by the Company to determine if the contract conveys the right to control an identified asset in exchange for consideration during a period of time. The Company classifies all identified leases as either operating or finance leases. As of both December 31,2024 and 2023, the Company was not a party to any finance leases. Contracts that contain leases are assessed to determine if the consideration in the contract is related to a lease component, non-lease component or other components not related to the lease. Lease components are recorded as right-of-use (“ROU”) assets and lease liabilities while any non-lease component is expensed as incurred. The consideration in the contract related to other components not related to the lease is allocated among the lease component and the non-lease component, as applicable, based on the stand-alone selling price of the lease and non-lease components.
Certain lease contracts may contain an option to extend or terminate the lease. The Company considers the economic impact of extension and termination options by contract. If the Company concludes it is reasonably certain an option will be exercised, that option is included in the lease term and impacts the amount recorded as an ROU asset and lease liability upon inception of the contract.
The Company's lease liability is determined by discounting the future cash flows over the lease period. The Company determines its discount rates utilizing current secured financing rates based on the length of the lease period plus the Company's margin over Term SOFR on the Term Loan. The Company believes this rate effectively represents a borrowing rate the Company could obtain on a debt instrument possessing similar terms as the lease. Lease liabilities are classified between current and non-current liabilities based on the terms of the underlying leases. The weighted average discount rate on operating leases as of December 31,2024 and 2023 was 4.84% and 4.75%, respectively.
As of December 31, 2024, the Company recorded current andnon-current operating lease liabilities of $6 million and $14 million, respectively. As of December 31, 2023, the Company recorded current andnon-current operating lease liabilities of $4 million and $14 million, respectively. The following table reconciles future undiscounted cash flows for operating leases to total operating lease liabilities as of December 31,2024 (dollars in millions):
| 2025 | $6 |
| 2026 | 5 |
| 2027 | 3 |
| 2028 | 4 |
| 2029 | 1 |
| Thereafter | 3 |
| Total lease payments | $22 |
| Less: Interest | 2 |
| Present value of operating lease liabilities | $20 |
ROU assets are calculated as the related lease liability adjusted for lease incentives, prepayments and the effect of escalating lease payments on period expense. The below table depicts the ROU assets recorded in Other non-current assets in the Consolidated Balance Sheets and held by the Company based on the following underlying assets (dollars in millions):
| December 31,2024 | December 31,2023 | |
|---|---|---|
| Buildings | $17 | $15 |
| Equipment | 1 | 2 |
| Land | 1 | 1 |
| Vehicles | 1 | 1 |
| Total ROU assets | $20 | $19 |
The weighted average remaining lease term as of December 31, 2024 and December 31, 2023 was 5.1 years and 5.6 years, respectively.
Operating lease expense was $7 million and $6 million for the years ended December 31, 2024 and 2023, respectively, and was recorded within Selling, general and administrative expense and Engineering — research and development on the Company's Consolidated Statements of Comprehensive Income. There wasno material short-term operating lease expense for either of the years ended December 31, 2024 or 2023.
During the years ended December 31, 2024 and 2023, the Company recorded $7 million and $6 million, respectively, of new ROU assets obtained in exchange for lease obligations.
NOTE 13. OTHER (EXPENSE) INCOME, NET
Other (expense) income, net consisted of the following (dollars in millions):
| Years ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Post-retirement benefit plan amendment credits | $10 | $9 | $9 |
| Unrealized loss on marketable securities | (9) | (1) | (22) |
| Loss on foreign exchange | (6) | (2) | (13) |
| Rabbi trust assets gain (loss) | 3 | 3 | (3) |
| Technology-related investments (loss) gain | (2) | 3 | 6 |
| Other | (2) | 3 | 2 |
| Total | $(6) | $15 | $(21) |
NOTE 14. OTHER CURRENT LIABILITIES
Other current liabilities consisted of the following (dollars in millions):
| December 31,2024 | December 31,2023 | |
|---|---|---|
| Payroll and related costs | $90 | $89 |
| Sales incentives | 42 | 41 |
| Accrued interest payable | 25 | 24 |
| Vendor buyback obligation | 19 | 18 |
| Taxes payable | 14 | 17 |
| Lease liability | 6 | 4 |
| OPEB liability | 4 | 5 |
| Other accruals | 17 | 14 |
| Total | $217 | $212 |
NOTE 15. EMPLOYEE BENEFIT PLANS
The Company provides defined benefit pension plans, defined contribution plans and/or other postretirement benefit plans to certain employees globally. However, contributions to the Company’s various international benefit plans are not material for the periods presented. The Company’s defined benefit pension plans generally provide benefits of negotiated, stated amounts for each year of service as well as significant supplemental benefits for eligible employees. The Company sponsors defined contribution retirement savings plans for eligible employees, based on employee location and status. The Company’s salaried defined contribution retirement savings plans provide for a Company match of employee contributions up to certain limits based upon eligible base salary. The charge to expense for the Company’s defined contribution retirement savings plans was $23 million, $18 million and $16 million for the years ended December 31, 2024, 2023 and 2022, respectively. The Company is also responsible for OPEB costs (medical, dental, vision, and life insurance) for hourly employees hired prior to May 19, 2008, excluding those employees eligible to retire at the time of the sale of the Company. The plan is unfunded and any future payments will be funded by the Company’s operating cash flows.
Obligations, Funded Status and Recognition in the Consolidated Balance Sheets
The following table provides a reconciliation of the changes in the benefit obligations, funded status and amounts recognized in the Consolidated Balance Sheets for the years ended December 31,2024 and 2023 (dollars in millions):
| Pension Plans | Post-retirement Benefits | |||
|---|---|---|---|---|
| Year endedDecember 31,2024 | Year endedDecember 31,2023 | Year endedDecember 31,2024 | Year endedDecember 31,2023 | |
| Benefit Obligations: | ||||
| Benefit obligation at beginning of year | $169 | $161 | $64 | $73 |
| Service cost | 4 | 4 | — | — |
| Interest cost | 7 | 8 | 3 | 4 |
| Plan settlements | (30) | — | — | — |
| Benefits paid | (9) | (12) | (5) | (5) |
| Actuarial (gain) loss | (11) | 8 | (3) | (8) |
| Benefit obligation at end of year | $130 | $169 | $59 | $64 |
| Fair Value of Plan Assets: | ||||
| Fair value of plan assets at beginning of year | $164 | $158 | $— | $— |
| Actual return on plan assets | 2 | 10 | — | — |
| Employer contributions | 5 | 8 | 5 | 5 |
| Plan settlements | (30) | — | — | — |
| Benefits paid | (9) | (12) | (5) | (5) |
| Fair value of plan assets at end of year | $132 | $164 | $— | $— |
| Net Funded Status | $2 | $(5) | $(59) | $(64) |
| Amounts Recognized in Balance Sheet: | ||||
| Non-current assets | $4 | $1 | $— | $— |
| Current liabilities | — | — | (4) | (4) |
| Non-current liabilities | (2) | (6) | (55) | (60) |
| Net amount recognized | $2 | $(5) | $(59) | $(64) |
| Accumulated Other Comprehensive Loss: | ||||
| Prior service credit | $1 | $1 | $5 | $14 |
| Actuarial loss (gain) | 3 | (7) | 32 | 33 |
| Total | $4 | $(6) | $37 | $47 |
The accumulated benefit obligation for the Company's pension plans as of December 31, 2024 and 2023 was $125 million and $164 million, respectively.
The table below provides the weighted-average actuarial assumptions used to determine the benefit obligations of the Company’s plans.
| Pension Plans · Post-retirement Benefits | ||||
|---|---|---|---|---|
| As of December 31, | ||||
| 2024 | 2023 | 2024 | 2023 | |
| Discount rate | 5.60% | 5.00% | 5.60% | 5.00% |
| Rate of compensation increase (salaried) | 3.00% | 3.00% | N/A | N/A |
The discount rate is used to determine the present value of the Company’s benefit obligations. The Company’s discount rate is determined by matching the plans’ projected cash flows to a yield curve based on long-term, fixed income debt instruments available as of the measurement date of December 31, 2024. The Company reviews all actuarial assumptions on an annual basis and in the case of remeasurement.
As of December 31,2024 and 2023, the projected benefit obligation, the accumulated benefit obligation, and the fair value of plan assets for pension plans with a projected benefit obligation in excess of plan assets and for pension plans with an accumulated benefit obligation in excess of plan assets were as follows (dollars in millions):
| Hourly Plan · Salary Plan | ||||
|---|---|---|---|---|
| As of December 31, | ||||
| 2024 | 2023 | 2024 | 2023 | |
| Plans with projected benefit obligation in excess of plan assets: | ||||
| Projected benefit obligation | N/A 1 | N/A 1 | $50 | $83 |
| Fair value of plan assets | N/A 1 | N/A 1 | $47 | $77 |
| Plans with accumulated benefit obligation in excess of plan assets: | ||||
| Accumulated benefit obligation | N/A 1 | N/A 1 | N/A 2 | $79 |
| Fair value of plan assets | N/A 1 | N/A 1 | N/A 2 | $77 |
(1)
As of December 31, 2024 and 2023, the hourly defined pension plan had plan assets greater than the projected benefit obligation and the accumulated benefit obligation.
(2)
As of December 31, 2024, the salary defined pension plan had plan assets greater than the accumulated benefit obligation.
Net Periodic Benefit Cost
Information about the net periodic benefit cost (credit) and other changes recognized in AOCL for the pension and post-retirement benefit plans is as follows (dollars in millions):
| Pension Plans | Post-retirement Benefits | |||||
|---|---|---|---|---|---|---|
| Year endedDecember 31,2024 | Year endedDecember 31,2023 | Year endedDecember 31,2022 | Year endedDecember 31,2024 | Year endedDecember 31,2023 | Year endedDecember 31,2022 | |
| Net Periodic Benefit Cost (Credit): | ||||||
| Service cost | $4 | $4 | $7 | $— | $— | $1 |
| Interest cost | 7 | 8 | 6 | 3 | 4 | 3 |
| Expected return on assets | (7) | (8) | (8) | — | — | — |
| Settlement loss | 4 | — | — | — | — | — |
| Prior service credit | (1) | — | (1) | (10) | (10) | (10) |
| Recognized actuarial loss (gain) | 1 | — | 1 | (3) | (2) | — |
| Net Periodic Benefit Cost (Credit) | $8 | $4 | $5 | $(10) | $(8) | $(6) |
| Other changes in other comprehensive (income) loss: | ||||||
| Net (gain) loss | $(4) | $6 | $(6) | $(3) | $(8) | $(29) |
| Amortizations | (5) | — | — | 13 | 12 | 10 |
| Total recognized – other comprehensive (income) loss | $(9) | $6 | $(6) | $10 | $4 | $(19) |
The components of net periodic benefit costs other than the service cost component are included in Other (expense) income, net in the Consolidated Statements of Comprehensive Income.
In June 2024, the Company completed a pension risk transfer to a third-party insurance company of a portion of its salaried defined benefit pension plan's obligations for certain participants and their beneficiaries. The Company agreed to an annuity contract that was purchased using pension plan assets, resulting in the transfer of $30 million of pension plan assets and $30 million of pension plan benefit obligations to the insurance company. As a result of this transaction, in the second quarter of 2024, the Company recognized a non-recurring, non-cash $4 million settlement charge for a pro rata portion of previously unrecognized pension plan actuarial net losses, which was recorded in Other (expense) income, net in the Consolidated Statements of Comprehensive Income.
The table below provides the weighted-average actuarial assumptions used to determine the net periodic benefit cost (credit).
| Pension Plans | Post-retirement Benefits | |||||
|---|---|---|---|---|---|---|
| Year endedDecember 31,2024 | Year endedDecember 31,2023 | Year endedDecember 31,2022 | Year endedDecember 31,2024 | Year endedDecember 31,2023 | Year endedDecember 31,2022 | |
| Discount rate | 5.00% | 5.20% | 2.70% | 5.00% | 5.20% | 2.80% |
| Rate of compensation increase (salaried) | 3.00% | 3.00% | 3.00% | N/A | N/A | N/A |
| Expected return on assets | 5.30% | 5.30% | 3.80% | N/A | N/A | N/A |
The overall expected rate of return on plan assets is based upon historical and expected future returns consistent with the expected benefit duration of the plan for each asset group adjusted for investment and administrative fees. Health care cost trends are used to project future post-retirement benefits payable from the
Company’s plans. As of December 31, 2024, future post-retirement health care costs were forecasted assuming an initial annual increase of up to 9.10%, decreasing to an annual increase of up to 4.00% by the year 2048. The Company reviews all actuarial assumptions on an annual basis and in the case of remeasurement.
Pension Plan Assets
The Company’s pension plan assets mostly consist of diversified equity securities and diversified debt securities. The fair values of plan assets for the Company’s pension plans as of December 31,2024 and 2023 are as follows (dollars in millions):
| Fair Value Measurements Using | ||||||
|---|---|---|---|---|---|---|
| Quoted Prices in ActiveMarkets for IdenticalAssets (Level 1) | Significant OtherObservable Inputs(Level 2) | TOTAL | ||||
| 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | |
| Diversified debt securities | $10 | $12 | $96 | $123 | $106 | $135 |
| Diversified equity securities | 15 | 18 | 6 | 7 | 21 | 25 |
| Cash equivalents | 5 | 4 | — | — | 5 | 4 |
| Total | $30 | $34 | $102 | $130 | $132 | $164 |
The Company’s investment strategy with respect to pension plan assets is to invest the assets in accordance with laws and regulations. The long-term primary objectives for the Company’s pension assets are to provide results that meet or exceed the plans’ actuarially assumed long-term rate of return without subjecting the funds to undue risk. To achieve these objectives the Company has established the following targets:
| Target | ||
|---|---|---|
| Asset Category | Hourly | Salary |
| Cash equivalents | 3% | 3% |
| Diversified equity securities | 15 | 15 |
| Diversified debt securities | 82 | 82 |
| Total | 100% | 100% |
Throughout 2024, the Company’s investment committee has continued to evaluate the investments and take steps toward the established targets.
Expected Contributions and Benefit Payments
Information about expected cash flows for the Company’s pension and post-retirement benefit plans is as follows (dollars in millions):
| PensionPlans · Post-retirementBenefits | ||
|---|---|---|
| Employer Contributions: | ||
| 2025 expected contributions | $— | $4 |
| Expected Benefit Payments: | ||
| 2025 | 9 | 4 |
| 2026 | 9 | 5 |
| 2027 | 10 | 4 |
| 2028 | 9 | 4 |
| 2029 | 10 | 4 |
| 2029-2033 | 53 | 23 |
Expected benefit payments for pension and post-retirement benefits will be paid from plan trusts or corporate assets. The Company’s funding policy is to contribute amounts annually that are at least equal to the amounts required by applicable laws and regulations or to directly fund payments to plan participants. Additional discretionary contributions will be made when deemed appropriate to meet the Company’s long-term obligation to the plans.
Non-qualified Deferred Compensation Plan
The Company maintains a non-qualified deferred compensation plan (“Deferred Compensation Plan”) for a select group of management. Under the terms of the plan, the Company has utilized a rabbi trust to accumulate assets to fund its promise to pay benefits under the Deferred Compensation Plan. The rabbi trust is an irrevocable trust, which restricts any use of funds (operational or otherwise) by the Company other than to pay benefits under the Deferred Compensation Plan, and prevents immediate taxation of contributed amounts. Funds are accumulated through both employee deferrals and a Company match. Funds can be invested by the employee into a diversified group of investment options, which have been selected by the Company’s investment committee, that are all categorized as Level 1 in the fair value hierarchy. The Company match resulted in $1 million of expense recorded to the Consolidated Statements of Comprehensive Income for each of the years ended December 31, 2024 and 2023. There wasno charge to the Consolidated Statements of Comprehensive Income for the year ended December 31,2022. The fair value of the rabbi trust plan assets and deferred compensation obligation was $20 million and $18 million as of December 31, 2024 and 2023, respectively.
NOTE 16. INCOME TAXES
Income before income taxes included the following (dollars in millions):
| Years ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| U.S. income | $878 | $776 | $621 |
| Foreign income | 19 | 51 | 24 |
| Total | $897 | $827 | $645 |
The provision for income tax expense was estimated as follows (dollars in millions):
| Years ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Current income taxes: | |||
| U.S. federal | $161 | $144 | $98 |
| U.S. state and local | 13 | 16 | 11 |
| Foreign | 9 | 11 | 9 |
| Total Current | 183 | 171 | 118 |
| Deferred income tax (benefit) expense, net: | |||
| U.S. federal | (13) | (15) | 5 |
| U.S. state and local | (3) | 2 | (3) |
| Foreign | (1) | (4) | (6) |
| Total Deferred | (17) | (17) | (4) |
| Total income tax expense | $166 | $154 | $114 |
A reconciliation of the provision for income tax expense compared with the amounts at the U.S. federal statutory rate is as follows (dollars in millions):
| Years ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Tax at U.S. statutory income tax rate | $189 | $174 | $136 |
| Foreign derived intangible income deduction | (29) | (25) | (13) |
| Tax credits | (14) | (15) | (9) |
| State tax expense (excluding tax rate changes) | 11 | 13 | 12 |
| Nontaxable or nondeductible items | 8 | 12 | 15 |
| Effect of tax rate changes | (3) | (4) | (15) |
| Valuation allowance | — | 2 | (6) |
| Other | 4 | (3) | (6) |
| Total income tax expense | $166 | $154 | $114 |
The effective tax rate for each of the years ended December 31, 2024 and 2023 was 19%.
Deferred income tax assets and liabilities as of December 31, 2024 and 2023 reflect the effect of temporary differences between amounts of assets, liabilities and equity for financial reporting purposes and the bases of such assets, liabilities and equity as measured by tax laws, as well as tax loss and tax credit carry forwards. Net deferred tax assets and liabilities are classified as non-current in the Consolidated Balance Sheets. As described above, the deferred tax assets and liabilities are measured based on the enacted tax rates that will apply in the years in which the temporary differences are expected to be recovered or paid.
The Company has not recognized any deferred tax liabilities associated with earnings in foreign subsidiaries, except for its subsidiary located in China, as they are intended to be permanently reinvested and used to support foreign operations or have no associated tax requirements. As of December 31, 2024, the Company has recorded a deferred tax liability of $3 million for the tax liability associated with the remittance of previously taxed income and unremitted earnings for its subsidiary located in China.
Temporary differences and carryforwards that gave rise to deferred tax assets and liabilities included the following(dollars in millions):
| December 31,2024 | December 31,2023 | |
|---|---|---|
| Deferred tax assets: | ||
| Capitalized research | $55 | $43 |
| Other accrued liabilities | 34 | 35 |
| Deferred revenue | 30 | 28 |
| Warranty accrual | 12 | 14 |
| Stock-based compensation | 9 | 8 |
| Tax credits | 8 | 8 |
| Inventories | 8 | 7 |
| Sales incentives | 7 | 7 |
| Other | 18 | 16 |
| Total deferred tax assets | 181 | 166 |
| Valuation allowances | (9) | (9) |
| Deferred tax liabilities: | ||
| Goodwill | (414) | (414) |
| Trade name | (176) | (178) |
| Property, plant and equipment | (61) | (61) |
| Post-retirement | (8) | (6) |
| Intangibles | (1) | (3) |
| Other | (3) | (5) |
| Total deferred tax liabilities | (663) | (667) |
| Net deferred tax liability | $(491) | $(510) |
Management has determined, based on an evaluation of available objective and subjective evidence, that it is more likely than not that certain federal and state deferred tax assets will not be realized; therefore, these deferred tax assets are offset with a valuation allowance of $9 million as of both December 31, 2024 and 2023.
The 2017 U.S. Tax Cuts and Jobs Act requires taxpayers to capitalize and amortize specified research and development expenditures over a period of five years for domestic or 15 years for foreign research, beginning with the tax years ending after December 31, 2021. As a result, the Company recognized a deferred tax asset of $55 million as of December 31,2024.
All of the Company's tax returns, once filed, will remain subject to examination by the various taxing authorities for the duration of the applicable statute of limitations (generally three years from the earlier of the date of filing or the due date of the return).
NOTE 17. ACCUMULATED OTHER COMPREHENSIVE LOSS
The changes in components of AOCL consisted of the following (dollars in millions):
| Pensionand OPEBliability adjustments | Interest rate swaps | Foreign currency items | Total | |
|---|---|---|---|---|
| AOCL as of December 31, 2021 | $(17) | $(24) | $(32) | $(73) |
| Other comprehensive income (loss) before reclassifications | 39 | 44 | (10) | 73 |
| Amounts reclassified from AOCL | (10) | 6 | — | (4) |
| Income tax expense | (7) | (11) | — | (18) |
| Net current period other comprehensive income (loss) | $22 | $39 | $(10) | $51 |
| AOCL as of December 31, 2022 | $5 | $15 | $(42) | $(22) |
| Other comprehensive income before reclassifications | 3 | 7 | 2 | 12 |
| Amounts reclassified from AOCL | (12) | (12) | — | (24) |
| Income tax benefit | 2 | 1 | — | 3 |
| Net current period other comprehensive (loss) income | $(7) | $(4) | $2 | $(9) |
| AOCL as of December 31, 2023 | $(2) | $11 | $(40) | $(31) |
| Other comprehensive income (loss) before reclassifications | 8 | 5 | (13) | — |
| Amounts reclassified from AOCL | (9) | (12) | — | (21) |
| Income tax benefit | — | 1 | — | 1 |
| Net current period other comprehensive loss | $(1) | $(6) | $(13) | $(20) |
| AOCL as of December 31, 2024 | $(3) | $5 | $(53) | $(51) |
The following table shows the location in the Consolidated Statements of Comprehensive Income affected by reclassifications from AOCL (dollars in millions):
| Amounts reclassified from AOCL | ||||
|---|---|---|---|---|
| AOCL Components | Year ended December 31, 2024 | Year ended December 31, 2023 | Year ended December 31, 2022 | Affected line item in the Consolidated Statements of Comprehensive Income |
| Interest rate swaps | $12 | $12 | $(6) | Interest expense, net |
| Prior service credit | 11 | 10 | 11 | Other (expense) income, net |
| Pension plan settlement loss | (4) | — | — | Other (expense) income, net |
| Recognized actuarial gain (loss) | 2 | 2 | (1) | Other (expense) income, net |
| Total reclassifications, before tax | 21 | 24 | 4 | Income before income taxes |
| Income tax expense | (5) | (5) | (1) | Income tax expense |
| Total reclassifications | $16 | $19 | $3 | |
Prior service credits, actuarial gains and pension settlement losses are included in the computation of the Company’s net periodic benefit cost (credit). Please see "Note 15. Employee Benefit Plans” for additional details.
NOTE 18. COMMITMENTS AND CONTINGENCIES
The Company is party to various legal actions and administrative proceedings and subject to various claims arising in the ordinary course of business. These proceedings primarily involve commercial claims, product liability claims, personal injury claims and workers’ compensation claims. The Company believes that the ultimate liability, if any, in excess of amounts already provided for in the consolidated financial statements or covered by insurance on the disposition of these matters will not have a material adverse effect on the financial position, results of operations or cash flows of the Company.
NOTE 19. CONCENTRATION OF RISK
As of December 31, 2024 and 2023, the Company employed approximately 4,000 and 3,700 employees, respectively, with 89% of those employees in the U.S. Approximately 50% and 48% of the Company’s U.S. employees were represented by unions and subject to a collective bargaining agreement as of December 31, 2024 and 2023, respectively. The Company is currently operating under a collective bargaining agreement with the International Union, United Automobile, Aerospace and Agricultural Implement Workers of America (“UAW”) Local 933 that expires in November 2027.
Three customers accounted for 10% or more of the Company's net sales within the last three years presented.
| Years ended December 31, | |||
|---|---|---|---|
| % of net sales | 2024 | 2023 | 2022 |
| Daimler AG | 20% | 18% | 20% |
| PACCAR Inc. | 13% | 11% | 9% |
| Traton SE | 11% | 11% | 10% |
Two cust omers accounted for 10% or more of the Company's outstanding accounts receivable within the last two years presented.
| % of accounts receivable | December 31,2024 | December 31,2023 |
|---|---|---|
| Daimler AG | 20% | 16% |
| Traton SE | 11% | 14% |
No supplier accounted for 10% or more of materials purchased during any of the years ended December 31, 2024, 2023 or 2022.
NOTE 20. COMMON STOCK
The Company's Board of Directors has authorized the Company to repurchase up to $4,000 million of its common stock pursuant to a stock repurchase program (the "Repurchase Program"). During 2024, the Company repurchased approximately $254 million of its common stock under the Repurchase Program, leaving $519 million of authorized repurchases remaining under the Repurchase Program as of December 31, 2024. The Repurchase Program has no termination date, and the timing and amount of stock purchases are subject to market conditions and corporate needs. The Repurchase Program may be modified, suspended or discontinued at any time at the Company’s discretion.
NOTE 21. EARNINGS PER SHARE
The following table reconciles the numerators and denominators used to calculate basic EPS and diluted EPS (in millions, except per share data):
| Years ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net income | $731 | $673 | $531 |
| Weighted average shares of common stock outstanding | 87 | 90 | 96 |
| Dilutive effect of stock-based awards | 1 | 1 | — |
| Diluted weighted average shares of common stock outstanding | 88 | 91 | 96 |
| Basic earnings per share attributable to common stockholders | $8.40 | $7.48 | $5.53 |
| Diluted earnings per share attributable to common stockholders | $8.31 | $7.40 | $5.53 |
The dilutive impact of stock-based compensation is calculated using the treasury stock method. The treasury stock method assumes that the Company uses the proceeds from the exercise of awards to repurchase common stock at the average market price during the period. During each of the years ended December 31, 2024 and 2023, there wereno outs tanding stock options that were anti-dilutive and excluded from the diluted EPS calculation. During the year ended December 31, 2022, there were 2 million of outstanding stock options that were anti-dilutive and excluded from the diluted EPS calculation. Basicand diluted EPS for the full-year are calculated using the weighted average shares of common stock outstanding during the year while quarterly basic and diluted EPS are calculated using the weighted average shares of common stock outstanding during the quarter; therefore, the sum of each quarter’s EPS may not equal full-year EPS.
NOTE 22. GEOGRAPHIC INFORMATION
The Company had the following net sales by country, based on the location of the customer (dollars in millions):
| Years ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| United States | $2,324 | $2,171 | $1,944 |
| China | 172 | 164 | 196 |
| Japan | 136 | 102 | 103 |
| Canada | 74 | 65 | 57 |
| Mexico | 73 | 51 | 41 |
| Germany | 47 | 49 | 44 |
| Other | 399 | 433 | 384 |
| Total | $3,225 | $3,035 | $2,769 |
The Company had the following net long-lived assets by country (dollars in millions):
| Years ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| United States | $757 | $738 | $730 |
| India | 31 | 20 | 19 |
| Hungary | 10 | 10 | 10 |
| Other | 5 | 6 | 4 |
| Total | $803 | $774 | $763 |
NOTE 23. SEGMENT INFORMATION
In accordance with the FASB’s authoritative accounting guidance on segment reporting, the Company hasone operating segment and reportable segment. The Company is managed by the CODM based on its one line of business, the design, manufacture and distribution of vehicle propulsion solutions.
The Company’s CODM is its Chair, President and Chief Executive Officer. The CODM evaluates Company performance and makes decisions on the allocation of resources based on Net income, a GAAP measure, and Adjusted Earnings before Interest, Taxes, Depreciation, and Amortization (“EBITDA”), a non-GAAP measure. The most directly comparable GAAP measure to Adjusted EBITDA is Net income. The Company believes that Net income and Adjusted EBITDA provide management, investors and creditors with useful measures of the operational results of its business and increase the period-to-period comparability of the Company's operating profitability and comparability with other companies.
The CODM assesses Company performance utilizing Net income and Adjusted EBITDA by comparing budget versus actual and year-over-year variances. Certain variances identified in the analysis of Net income and Adjusted EBITDA are evaluated to assist the CODM in assessing Company performance and making decisions on the allocation of Company resources. The following expenses included in Net income and Adjusted EBITDA are identified as significant expenses regularly provided to the CODM: Cost of sales, Selling, general and administrative, and Engineering— research and development.
The Company’sone reportable segment is the same as its consolidated financial results; therefore, segment information for additions of long-lived assets and asset information can be found in the Company’s consolidated statements of cash flows and consolidated balance sheets, respectively.
The following presents a financial summary of the Company’s one reportable segment (dollars in millions):
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Revenue | $3,225 | $3,035 | $2,769 |
| less: | |||
| Cost of sales | 1,696 | 1,565 | 1,472 |
| Selling, general and administrative | 337 | 357 | 328 |
| Engineering — research and development | 200 | 194 | 185 |
| Other segment items (a) | 261 | 246 | 253 |
| Net income (GAAP) | 731 | 673 | 531 |
| plus: | |||
| Income tax expense | 166 | 154 | 114 |
| Depreciation of property, plant and equipment | 111 | 109 | 109 |
| Interest expense, net | 89 | 107 | 118 |
| Amortization of intangible assets | 10 | 45 | 46 |
| Other adjustments (b) | 58 | 20 | 43 |
| Adjusted EBITDA (Non-GAAP) | $1,165 | $1,108 | $961 |
| Total assets | $5,336 | $5,025 | $4,671 |
(a)
Represents other segment items included in Net income including Interest expense, net, Income tax expense and Other (expense) income, net.
(b)
Represents other reconciling items between Net income and Adjusted EBITDA.
Schedule I—Parent Company only Balance Sheets
| December 31, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| Current Assets: | ||
| Cash | $— | $— |
| Total Current Assets | — | — |
| Investments in and advances to subsidiaries | 1,651 | 1,233 |
| TOTAL ASSETS | $1,651 | $1,233 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current Liabilities: | ||
| Accounts payable | $— | $— |
| Total Current Liabilities | — | — |
| Capital stock | 1 | 1 |
| Paid in capital | 1,940 | 1,891 |
| Accumulated deficit | (239) | (628) |
| Accumulated other comprehensive loss, net of tax | (51) | (31) |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $1,651 | $1,233 |
Schedule I—Parent Company only Statements of Comprehensive Income
| Years ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net sales | $— | $— | $— |
| General and administrative fees | — | — | — |
| Total operating income | — | — | — |
| Other income: | |||
| Equity earnings of consolidated subsidiary | 731 | 673 | 531 |
| Income before income taxes | 731 | 673 | 531 |
| Income tax expense | — | — | — |
| Net income | $731 | $673 | $531 |
| Comprehensive income | $711 | $664 | $582 |
Schedule I—Parent Company only Statements of Cash Flows
| Years ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||
| Net income | $731 | $673 | $531 |
| Deduct items included in net income not providing cash: | |||
| Equity in earnings in consolidated subsidiary | (731) | (673) | (531) |
| Net cash provided by operating activities | — | — | — |
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||
| Investments in subsidiaries | (32) | (28) | (2) |
| Dividends | 87 | 83 | 80 |
| Net cash provided by investing activities | 55 | 55 | 78 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||
| Capital contributions | 32 | 28 | 2 |
| Dividends | (87) | (83) | (80) |
| Net cash used in financing activities | (55) | (55) | (78) |
| Net increase (decrease) during period | — | — | — |
| Cash and cash equivalents at beginning of period | — | — | — |
| Cash and cash equivalents at end of period | $— | $— | $— |
Schedule I—Parent Company only Footnote
NOTE 1—BASIS OF PRESENTATION
Allison Transmission Holdings, Inc. (the “Parent Company”) is a holding company that conducts all of its business operations through its subsidiaries. There are restrictions on the Parent Company’s ability to obtain funds from its subsidiaries through dividends (refer to "Note 8. Debt” of Notes to Consolidated Financial Statements). The entire amount of the Parent Company’s consolidated net assets was subject to restrictions on payment of dividends as of December 31, 2024, 2023 and 2022. Accordingly, these financial statements have been presented on a “parent-only” basis. Under a parent-only presentation, the Parent Company’s investments in its consolidated subsidiaries are presented under the equity method of accounting. These parent-only financial statements should be read in conjunction with Allison Transmission Holdings, Inc.’s audited Consolidated Financial Statements included elsewhere herein.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.